Reducing the impact of migraine on functioning: Results from the STRIVE trial, a phase 3, randomised, double-blind, placebo-controlled study of erenumab in patients with episodic migraine

被引：0
|
作者：
Buse, Dawn C. [1 ,2 ]
Lipton, Richard B. [1 ,2 ]
Mikol, Daniel D. [3 ]
Thach, Andrew V. [3 ]
Desai, Pooja [3 ]
Picard, Hernan [3 ]
Kubo, Yumi [3 ]
Hareendran, Asha [4 ]
Kawata, Ariane K. [5 ]
机构：
[1] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Evidera, London, England
[5] Evidera, Bethesda, MD USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P98
引用
收藏
页数：2
相关论文
共 50 条
  • [41] VERAPAMIL PROPHYLAXIS OF MIGRAINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    SOLOMON, GD
    STEEL, JG
    SPACCAVENTO, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (18): : 2500 - 2502
  • [42] A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
    Dzator, Jemima S. A.
    Howe, Peter R. C.
    Coupland, Kirsten G.
    Wong, Rachel H. X.
    NUTRIENTS, 2022, 14 (09)
  • [43] Double-blind placebo-controlled trial of tonabersat in the preventive management of migraine
    Goadsby, P. J.
    Ferrari, M. D.
    Olesen, J.
    Mills, J. G.
    CEPHALALGIA, 2007, 27 (10) : 1195 - 1196
  • [44] Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
    Ashina, Messoud
    Saper, Joel
    Cady, Roger
    Schaeffler, Barbara A.
    Biondi, David M.
    Hirman, Joe
    Pederson, Susan
    Allan, Brent
    Smith, Jeff
    CEPHALALGIA, 2020, 40 (03) : 241 - 254
  • [45] A PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSSOVER TRIAL OF FLUNARIZINE IN COMMON MIGRAINE
    SORENSEN, PS
    HANSEN, K
    OLESEN, J
    CEPHALALGIA, 1986, 6 (01) : 7 - 14
  • [46] Efficacy of erenumab (AMG 334) in patients with chronic migraine in North America and Europe: Subgroup analysis of a phase 2, randomised, double-blind, placebo-controlled study
    Reuter, U.
    Brandes, J.
    Dolezil, D.
    Tepper, S.
    Cheng, S.
    Leonardi, D.
    Lenz, R.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 548 - 548
  • [47] Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial
    Lakshmi, C. V. S.
    Singhi, Pratibha
    Malhi, Prahbhjot
    Ray, MLinni
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (07) : 829 - 835
  • [48] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
    MURPHY, JJ
    HEPTINSTALL, S
    MITCHELL, JRA
    LANCET, 1988, 2 (8604): : 189 - 192
  • [49] Responder Rates to Atogepant in Patients With Episodic Migraine: A Post Hoc Analysis of Results From a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, David W.
    Ailani, Jessica
    Goadsby, Peter J.
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Li, Ye
    Szegedi, Armin
    CEPHALALGIA, 2019, 39 : 183 - 184
  • [50] Responder Rates to Atogepant in Patients with Episodic Migraine: A Post Hoc Analysis of Results from a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, D. W.
    Ailani, J.
    Goadsby, P. J.
    Trugman, J. M.
    Finnegan, M.
    Lakkis, H.
    Li, Y.
    Szegedi, A.
    HEADACHE, 2019, 59 : 79 - 80
12345